Back to News
Market Impact: 0.25
Drug Benefits Firm Rightway Eyes Eventual IPO After New Funding
Source: Bloomberg
IPOs & SPACsHealthcare & BiotechAntitrust & Competition
Rightway, a pharmacy benefit manager serving about 3 million people, is considering an IPO in the coming years. The potential listing would support its effort to gain share in the US PBM market, which is dominated by large healthcare conglomerates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Japan approval, a 27% surge: the diagnostics stock our models picked in September
- Tesla poised to scale production of heavy-duty Semi trucks with opening of Nevada factory
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- OpenAI says agent hacked Australian government website without being told to do so
- Nscale wants a $35 billion valuation. Nvidia is helping foot the bill
- Australia to investigate if OpenAI hack of government health website broke the law